WO2021133191A1 - Состав для реминерализации эмали зубов - Google Patents
Состав для реминерализации эмали зубов Download PDFInfo
- Publication number
- WO2021133191A1 WO2021133191A1 PCT/RU2019/001020 RU2019001020W WO2021133191A1 WO 2021133191 A1 WO2021133191 A1 WO 2021133191A1 RU 2019001020 W RU2019001020 W RU 2019001020W WO 2021133191 A1 WO2021133191 A1 WO 2021133191A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- enamel
- teeth
- agent
- treatment
- agent according
- Prior art date
Links
- 210000003298 dental enamel Anatomy 0.000 title claims abstract description 56
- 230000000395 remineralizing effect Effects 0.000 title claims description 14
- 239000000203 mixture Substances 0.000 title description 50
- 238000011282 treatment Methods 0.000 claims abstract description 48
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 39
- 208000004042 dental fluorosis Diseases 0.000 claims abstract description 32
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 24
- 239000011707 mineral Substances 0.000 claims abstract description 24
- 206010016818 Fluorosis Diseases 0.000 claims abstract description 23
- 150000003839 salts Chemical class 0.000 claims abstract description 17
- 239000003755 preservative agent Substances 0.000 claims abstract description 4
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 3
- 230000002335 preservative effect Effects 0.000 claims abstract description 3
- 239000004615 ingredient Substances 0.000 claims abstract 3
- 230000002265 prevention Effects 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 14
- 230000006378 damage Effects 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 3
- 229960002216 methylparaben Drugs 0.000 claims description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 239000005844 Thymol Substances 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- 229960004365 benzoic acid Drugs 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 229960005323 phenoxyethanol Drugs 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 229940068977 polysorbate 20 Drugs 0.000 claims description 2
- 239000004302 potassium sorbate Substances 0.000 claims description 2
- 235000010241 potassium sorbate Nutrition 0.000 claims description 2
- 229940069338 potassium sorbate Drugs 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 229960003885 sodium benzoate Drugs 0.000 claims description 2
- 235000010268 sodium methyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- PESXGULMKCKJCC-UHFFFAOYSA-M sodium;4-methoxycarbonylphenolate Chemical compound [Na+].COC(=O)C1=CC=C([O-])C=C1 PESXGULMKCKJCC-UHFFFAOYSA-M 0.000 claims description 2
- 229960000790 thymol Drugs 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 abstract description 16
- 238000005115 demineralization Methods 0.000 abstract description 12
- 230000002328 demineralizing effect Effects 0.000 abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 6
- 239000001736 Calcium glycerylphosphate Substances 0.000 abstract description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract description 5
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 abstract description 5
- 229940095618 calcium glycerophosphate Drugs 0.000 abstract description 5
- 235000019299 calcium glycerylphosphate Nutrition 0.000 abstract description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract description 5
- 238000011321 prophylaxis Methods 0.000 abstract description 5
- 239000000811 xylitol Substances 0.000 abstract description 5
- 235000010447 xylitol Nutrition 0.000 abstract description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract description 5
- 229960002675 xylitol Drugs 0.000 abstract description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 abstract description 4
- 229920002907 Guar gum Polymers 0.000 abstract description 3
- 230000005221 enamel hypoplasia Effects 0.000 abstract description 3
- 235000011187 glycerol Nutrition 0.000 abstract description 3
- 239000000665 guar gum Substances 0.000 abstract description 3
- 235000010417 guar gum Nutrition 0.000 abstract description 3
- 229960002154 guar gum Drugs 0.000 abstract description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 abstract description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 abstract 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 37
- 150000002222 fluorine compounds Chemical class 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 239000000606 toothpaste Substances 0.000 description 10
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 9
- 208000002925 dental caries Diseases 0.000 description 9
- 239000011737 fluorine Substances 0.000 description 9
- 229910052731 fluorine Inorganic materials 0.000 description 9
- 210000000214 mouth Anatomy 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 229940034610 toothpaste Drugs 0.000 description 7
- 239000012025 fluorinating agent Substances 0.000 description 6
- 230000007170 pathology Effects 0.000 description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 210000003296 saliva Anatomy 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 241000519995 Stachys sylvatica Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229960005069 calcium Drugs 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000005299 abrasion Methods 0.000 description 3
- 230000033558 biomineral tissue development Effects 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 210000004268 dentin Anatomy 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000004283 incisor Anatomy 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000011775 sodium fluoride Substances 0.000 description 3
- 235000013024 sodium fluoride Nutrition 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000035154 Hyperesthesia Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000001720 vestibular Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 208000004509 Tooth Discoloration Diseases 0.000 description 1
- 206010044032 Tooth discolouration Diseases 0.000 description 1
- 206010044038 Tooth erosion Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000016674 enamel mineralization Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- -1 fluoride ions Chemical class 0.000 description 1
- 235000007983 food acid Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229960002337 magnesium chloride Drugs 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 239000011742 magnesium glycerophosphate Substances 0.000 description 1
- 235000001130 magnesium glycerophosphate Nutrition 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- BHJKUVVFSKEBEX-UHFFFAOYSA-L magnesium;2,3-dihydroxypropyl phosphate Chemical compound [Mg+2].OCC(O)COP([O-])([O-])=O BHJKUVVFSKEBEX-UHFFFAOYSA-L 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000001089 mineralizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 238000009516 primary packaging Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- WXSLOYPZKHFWII-UHFFFAOYSA-N propyl 4-hydroxybenzoate;sodium Chemical compound [Na].CCCOC(=O)C1=CC=C(O)C=C1 WXSLOYPZKHFWII-UHFFFAOYSA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- 235000010215 titanium dioxide Nutrition 0.000 description 1
- 230000036367 tooth discoloration Effects 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/20—Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
- A61K6/69—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/30—Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/70—Preparations for dentistry comprising inorganic additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/70—Preparations for dentistry comprising inorganic additives
- A61K6/71—Fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the invention relates to dentistry, and specifically to a new agent or composition in the form of a gel, intended for the treatment and / or prevention of conditions or diseases (disorders) characterized by the loss of minerals and salts from tooth enamel, its use and a method of treatment with it using.
- Tooth enamel is a protective tissue of the tooth.
- the enamel contains 96-97% mineral salts and 3-4% organic substances.
- the process of removing minerals from enamel is called "demineralization".
- demineralization can be malnutrition, characterized by the absence of vitamins and minerals in the diet or the presence of a large amount of fruit acids in it; mechanical damage to the tooth tissue, too frequent or unprofessional bleaching; bacterial damage to the teeth.
- undesirable conditions arise, characterized by the fact that the tooth enamel changes in color, becomes porous and rough, and chipping is possible. Teeth become sensitive, cavities develop.
- Natural remineralization of the tooth surface is carried out due to the action of saliva: it provides cleansing of the oral cavity from food debris, the buffering properties of saliva ensure its ability to neutralize the action of food acids to the maximum limit.
- the saliva contains remineralization initiators: calcium, fluorine and phosphate ions.
- remineralization initiators calcium, fluorine and phosphate ions.
- composition containing both calcium ions and fluoride ions is a topical agent known from application RU2003101428 for the prevention and treatment of caries, hyperesthesia of teeth in the form of a biocompatible polymer film made of hydrophobic and hydrophilic layers, including a fluorion source, antimicrobial component, calcium compounds, phosphorus-containing compounds and auxiliary substances.
- the dental gel according to the patent RU2677231 is characterized by the fact that it contains hydroxyapatite, fluorohydroxyapatite and sodium fluoride.
- the agent for the treatment of periodontal diseases which has an additional remineralizing effect, according to patent RU2361600, contains dry extract of black currant leaves as active components of a plant substance.
- dry extract of black currant leaves as active components of a plant substance.
- us as well as water, glycerin, a water-soluble cellulose derivative, calcium glycerophosphate, sodium fluoride, propylparaben sodium salt, fructose, peppermint oil.
- the clinical picture of dental fluorosis, as well as its intensity, depend not only on the amount of fluoride compounds entering the body from different sources, but also on the time of their toxic effects on the body, especially during the period of active growth, and the degree of individual susceptibility to fluoride compounds.
- Fluoride compounds are widespread in nature and are a constituent part of the tissues of human organs. These compounds can enter the atmosphere from waste and emissions from the aluminum and chemical industries. In connection with the development of industrial centers, fluoride compounds turn out to be one of the most frequent pollutants of water, soil and air. When contaminated food and water are consumed, 75-90% of these compounds from their total number enter the human body. They enter the human body through the gastrointestinal tract and are adsorbed from the air by the lungs, skin, mucous membranes. It is assumed that the accumulation of fluorides in human tissues and organs is uneven. Their maximum number is observed in the bones and surface layers of the tooth enamel (up to 100 microns thick), and the highest adsorption is observed during the entire period of active growth in childhood and adolescence.
- composition is an agent for remineralization of hard dental tissues according to patent RU2627624, which contains hydroxyapatite, highly purified, with a particle size of 20x150 nm as an active component and polyethylene oxides 1500 and 400, which constitute the basis of the agent.
- the inventors of this patent indicate a better remineralizing effect of the agent disclosed in the patent compared to a fluorine-containing composition.
- composition for the prevention of diseases of the oral cavity in the form of a toothpaste which has a remineralizing effect, presented in patent RU2293551, contains glycerin, silicon dioxide, calcium glycerophosphate, methylparaben, propylparaben, titanium dioxide, perfume, sodium saccharinate, sodium lauryl sulfate or alkylamidobetaine, drinking water, as well as the proteolytic enzyme bromelain, obtained from pineapple stems, natural sweetener, xylanthylene, xylanthine, and xylanthine or magnesium glycerophosphate.
- the prototype of the present invention is a composition in the form of a gel for remineralization of dental tissues according to patent EA011254, which contains, as active components, wt%: xylitol 2-25, calcium glycerophosphate 0.1-3.0, a source of magnesium ions 0, 01-0.50 and guar gum 0.03-0.30, as well as inert components used for the preparation of dental gels.
- This composition is used to prevent caries, treat non-carious lesions, including dental hyperesthesia, and improve the appearance (color and shine) of teeth.
- composition disclosed in the patent is not used for the treatment and / or prevention of conditions and disorders characterized by the loss of minerals and salts from tooth enamel.
- the problem is also solved by the use of such a gel for the treatment and / or prevention of conditions characterized by the loss of minerals and salts from the enamel of the teeth, as well as by the proposed method of treatment using such a composition in the form of a gel.
- the problem is also solved by a method for the treatment and / or prevention of conditions characterized by the loss of minerals and salts from the enamel of the teeth, which provides for the application to the surface of the teeth of a remineralizing agent in an effective amount, characterized in that the agent according to the invention is used as a remineralizing agent, moreover, this agent is applied in a mode 1-3 times a day, in a sufficient amount, while ensuring its presence on a substantially significant or larger surface of the teeth for at least 3 minutes, preferably at least 7 minutes, more preferably 15 minutes, even more preferably at least 1 hour to achieve the greatest effect.
- the technical result manifested when using the group of inventions is a fast, effective and practically convenient treatment or prevention of conditions characterized by the loss of minerals and salts from the enamel of the teeth.
- Ease of treatment ensures patient adherence to such therapy, which is essential for achieving treatment or prevention goals.
- the conditions requiring prophylaxis or treatment include demineralization, hypomineralization of teeth, the formation of carious spots on the enamel of the teeth that appear during or after orthodontic treatment using fixed equipment, the emergence and development of dental fluorosis, characterized by the appearance of chalky, white light or pigmented spots, destruction of enamel.
- the claimed gel is characterized by excellent organoleptic properties and aesthetically pleasing in appearance, which is important for ensuring patient adherence to treatment and prevention with this composition.
- the proposed composition does not contain fluorinating agents, the remineralizing effect is provided by the presence of active ingredients, including xylitol, calcium glycerophosphate, magnesium chloride and guar gum.
- active ingredients including xylitol, calcium glycerophosphate, magnesium chloride and guar gum.
- inventive composition is superior to fluorine-containing analogs in efficiency and is distinguished by toxicological safety and is preferably recommended for use in conditions when the water used in everyday life does not exclude an excess of the level of fluorine-containing components or the ecological situation does not exclude an excess of fluorine-containing substances.
- the present invention is directed to the prevention and treatment of conditions characterized by the loss of minerals and salts from tooth enamel. These conditions include demineralization, hypomineralization of teeth, fluorosis, especially fluorosis in milder forms, a stain formed or formed on the enamel, in particular, a stain characterized by the subsequent appearance of a carious cavity on the enamel, which arose during or after orthodontic treatment on fixed structures, further requiring the use of filling materials or veneers.
- the present invention in one context is directed to the prevention and / or elimination of the formation of chalky, white, pigmented or other stains that occur during or after orthodontic treatment on fixed structures.
- Specific examples of such designs are various bracket systems.
- Braces can be made of metal, ceramics, plastic.
- Braces are non-removable retainers, self-ligating braces, invisible braces, etc.
- the resulting stain depending on the severity of the disease, can be characterized by the appearance of a carious cavity on the enamel, the treatment of which may require the use of filling materials or veneers.
- the present invention in yet another context is directed to the prevention and / or elimination of the resulting chalky, white, pigmented or other stains caused by fluorosis.
- the present invention in yet another context is directed to the prevention and / or elimination of the resulting enamel disorders caused by fluorosis.
- the claimed composition may contain auxiliary components, which may be selected from those presented below, but are not limited to them.
- the claimed agent includes in its composition a nonionic surfactant, which can be polysorbate-20, PEG-40 hydrogenated castor oil, alkyl polyglycoside.
- a nonionic surfactant which can be polysorbate-20, PEG-40 hydrogenated castor oil, alkyl polyglycoside.
- the claimed agent includes in its composition a preservative, which may be methylparaben, sodium methylparaben, phenoxyethanol, benzoic acid, sodium benzoate, potassium sorbate, thymol.
- a preservative which may be methylparaben, sodium methylparaben, phenoxyethanol, benzoic acid, sodium benzoate, potassium sorbate, thymol.
- the claimed agent includes in its composition a perfume, which can be mint oil, eucalyptus oil, geranium oil, orange oil and similar components.
- the claimed product For effective remineralization of teeth, it is recommended to apply the claimed product to the teeth in an amount of 0.5-1.5 grams, 1-2 times a day when used in aligners, or up to 5 times a day when used without aligners, for 15 days.
- the declared agent For the treatment of defects in the form of stains that have arisen during or after orthodontic treatment on the enamel of teeth using a fixed technique, or which are a manifestation of fluorosis, it is recommended to apply the declared agent to the teeth in an amount of 0.5-1.5 grams, 1-2 times a day when used in a tray, or up to 5 times a day if used without a tray, for 30 days.
- Preventive modes of use of the claimed agent are approximately from 1/4 to 1/2 the amount of the composition per intake from those mentioned above, while the same mode can be applied.
- the doses presented are not limiting and can be changed depending on the degree or complexity of the disease.
- Gel formulations can be prepared using standard techniques.
- compositions were prepared as follows.
- the required amount of water was weighed in a measurer, then water was loaded into the mixer, where the remaining components of the gel were added under normal conditions. The mixture was stirred until a clear, uniform gel solution was formed over 20 minutes. Next, the primary packaging was carried out.
- Clinical parameters of the oral cavity were assessed in 18 schoolchildren 12 years old before remineralizing therapy and after therapy, 15 days later. The participants were divided into three groups of 6 people in each group. After appropriate training, the students were given the required amount of gels N ° 1,2,3, standard mouth guards and toothpastes that did not contain fluoride compounds. All schoolchildren applied the gel on their own for 20 minutes, after brushing their teeth, before going to bed. In the experiment, the clinical parameters of the TER test, the KOSRE test by the intensity of staining (points) and the KOSRE test by the duration of staining (days) were measured.
- TER test test for determining enamel resistance (Okushko V.R., Kosareva L.I., 1983) allows to determine the indicator of acid resistance of enamel and predisposition to dental caries.
- KOSRE-test clinical assessment of the rate of remineralization of tooth enamel (Redinova T.L., Leontyev V.K., 1982) allows to assess the ratio of de- and remineralization processes of tooth enamel in the patient's oral cavity.
- composition 2 is more effective than composition 1, a further increase in the concentration of active ingredients does not lead to a significant increase in efficiency, but leads to an increase in the cost of the entire composition.
- composition 1 a lower content of xylitol is also undesirable due to a decrease in the effectiveness of the action.
- composition 2 For further study, a gel of composition 2 was selected, as it showed the best results in a comparative study.
- Example 3 The effectiveness of the product when used in patients who have completed orthodontic treatment with a bracket system.
- the collection and processing of data was carried out in 2018 - 2019.
- the condition for inclusion in the studies was the presence of chalky or white spots in patients, formed during the wearing of the bracket system or after its removal, as well as the use of a toothpaste that does not contain fluorinating agents.
- Half of the study participants used a fluoride-free toothpaste, applying it twice a day for at least three minutes.
- the other half of the study participants (the second group) used the gel according to the “best” composition, applying it twice a day for 10-12 minutes after brushing the teeth with a paste that does not contain fluorinating agents according to the scheme used in the first group, then the patients put on a mouthguard , and restricting food and drink intake for an hour after application of the gel.
- bracket system The terms for removing the bracket system were less than six months, six months - a year, 1-3 years.
- the experience of using the gel in the study participants was positive. They rated the taste of the gel as good (fruity, refreshing) and the consistency as pleasant. The use of the gel made the teeth smoother, cleaner and more radiant. Gel so- it eliminated hypersensitivity, gave fresh breath, and facilitated the process of brushing teeth. Since the gel does not contain protein according to the “best” composition, unlike products based on the amorphous calcium phosphate-phosphopeptide complex from casein, it can be recommended for patients who are allergic to cow's milk proteins.
- This self-care option can be recommended to patients already at the beginning of orthodontic treatment or immediately after its completion, when a problem is revealed when removing the device.
- a positive result of the treatment was achieved, including in patients who suffered from white spots for many years after the completion of treatment with braces. The period of this study, 4-8 weeks, can be regarded as sufficient for a reliable effect of remineralization and elimination of its negative consequences.
- Example 4 Use of the agent in patients with fluorosis.
- the study aimed at determining the therapeutic and prophylactic efficacy of the gel according to the “best composition” was carried out for half a year.
- 30 people with a mild form of dental fluorosis and 30 people without manifestations of pathology of hard dental tissues in the form of fluorosis were selected.
- the subjects were divided into groups of 15 people
- the first group carried out professional oral hygiene with the use of non-fluorinating agents of toothpaste in combination with the intake of a vitamin-mineral complex
- the second group carried out professional oral hygiene using non-fluorinating agents of toothpaste in combination with a gel according to the “best” composition in the form of applications using an individual tray for 20 minutes daily, patients were asked not to eat or drink for 1 hours after applications;
- the third group performed professional oral hygiene using non-fluorinating toothpaste agents in combination with teeth whitening with an active gel containing 16% hydrogen peroxide;
- the fourth group is a control group without manifestations of fluorosis.
- the subjects carried out professional oral hygiene using a toothpaste that did not contain fluorinating agents.
- the calculation of the index of remineralization of each individual patient was carried out by summing the indicators of staining of fluoric spots to the number of studied teeth.
- the existing recommended method of whitening pigmented enamel using 16% peroxide gels, as well as The vitamin-mineral complex solves the problem only partially, while the gel (composition) proposed by the present invention provides, when applied according to the proposed method, the maximum effect of restoring the mineral composition of tooth enamel in the case of mild forms of fluorosis.
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022535093A JP7439352B2 (ja) | 2019-12-26 | 2019-12-26 | 歯のエナメル質を再石灰化するための組成物 |
PCT/RU2019/001020 WO2021133191A1 (ru) | 2019-12-26 | 2019-12-26 | Состав для реминерализации эмали зубов |
US17/789,098 US20230034815A1 (en) | 2019-12-26 | 2019-12-26 | Composition for remineralizing tooth enamel |
EP19957491.4A EP4082511A4 (en) | 2019-12-26 | 2019-12-26 | COMPOSITION FOR THE REMINERALIZATION OF DENTAL ENAMEL |
BR112022012549A BR112022012549A2 (pt) | 2019-12-26 | 2019-12-26 | Composição para remineralizar esmalte dentário |
RU2020128080A RU2779298C2 (ru) | 2019-12-26 | Состав для лечения и/или профилактики заболеваний, характеризующихся утратой минералов и солей из эмали зубов, и способ его применения | |
CN201980103366.2A CN114929179A (zh) | 2019-12-26 | 2019-12-26 | 用于使牙釉质再矿化的组合物 |
KR1020227025643A KR20220119700A (ko) | 2019-12-26 | 2019-12-26 | 치아 에나멜을 재광화하기 위한 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU2019/001020 WO2021133191A1 (ru) | 2019-12-26 | 2019-12-26 | Состав для реминерализации эмали зубов |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021133191A1 true WO2021133191A1 (ru) | 2021-07-01 |
Family
ID=76573121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU2019/001020 WO2021133191A1 (ru) | 2019-12-26 | 2019-12-26 | Состав для реминерализации эмали зубов |
Country Status (7)
Country | Link |
---|---|
US (1) | US20230034815A1 (ru) |
EP (1) | EP4082511A4 (ru) |
JP (1) | JP7439352B2 (ru) |
KR (1) | KR20220119700A (ru) |
CN (1) | CN114929179A (ru) |
BR (1) | BR112022012549A2 (ru) |
WO (1) | WO2021133191A1 (ru) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2003101428A (ru) | 2003-01-21 | 2004-07-27 | Ара Гарникович Чухаджян | Лечебно-профилактическое средство местного действия в виде самоклеящейся пленки для реминерализации твердых тканей зубов |
RU2293551C1 (ru) | 2005-05-23 | 2007-02-20 | Ооо "Вдс" | Состав для профилактики заболеваний полости рта |
RU2311168C2 (ru) * | 2006-01-26 | 2007-11-27 | Общество С Ограниченной Ответственностью "Вдс" | Состав для реминерализации тканей зубов |
EA011254B1 (ru) | 2008-02-07 | 2009-02-27 | Общество С Ограниченной Ответственностью "Вдс" | Гель для реминерализации тканей зубов |
RU2361600C1 (ru) | 2007-12-25 | 2009-07-20 | Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Федерального агентства по здравоохранению и социальному развитию (ГОУВПО ММА им. И.М. Сеченова Росздрава) | Средство для лечения заболеваний пародонта |
RU2627624C1 (ru) | 2016-10-06 | 2017-08-09 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) | Средство для реминерализации твердых тканей зубов |
RU2677231C1 (ru) | 2017-10-10 | 2019-01-16 | Федеральное государственное бюджетное учреждение науки Институт химии твердого тела Уральского отделения Российской академии наук | Стоматологический гель для реминерализации твердых тканей зубов и способ реминерализации твердых тканей зубов |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5645853A (en) * | 1995-08-08 | 1997-07-08 | Enamelon Inc. | Chewing gum compositions and the use thereof for remineralization of lesions in teeth |
RU2238078C1 (ru) | 2003-01-21 | 2004-10-20 | Чухаджян Ара Гарникович | Лечебно-профилактическое средство местного действия в виде самоклеящейся пленки для реминерализации твердых тканей зубов |
KR101234172B1 (ko) * | 2005-11-25 | 2013-02-19 | "더블유디에스"컴퍼니 | 구강 치료 및 예방 조성물 |
EA012247B1 (ru) * | 2008-07-07 | 2009-08-28 | Общество С Ограниченной Ответственностью "Вдс" | Лечебно-профилактический состав для ухода за полостью рта |
-
2019
- 2019-12-26 CN CN201980103366.2A patent/CN114929179A/zh active Pending
- 2019-12-26 WO PCT/RU2019/001020 patent/WO2021133191A1/ru unknown
- 2019-12-26 JP JP2022535093A patent/JP7439352B2/ja active Active
- 2019-12-26 EP EP19957491.4A patent/EP4082511A4/en active Pending
- 2019-12-26 US US17/789,098 patent/US20230034815A1/en active Pending
- 2019-12-26 BR BR112022012549A patent/BR112022012549A2/pt active Search and Examination
- 2019-12-26 KR KR1020227025643A patent/KR20220119700A/ko active Search and Examination
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2003101428A (ru) | 2003-01-21 | 2004-07-27 | Ара Гарникович Чухаджян | Лечебно-профилактическое средство местного действия в виде самоклеящейся пленки для реминерализации твердых тканей зубов |
RU2293551C1 (ru) | 2005-05-23 | 2007-02-20 | Ооо "Вдс" | Состав для профилактики заболеваний полости рта |
RU2311168C2 (ru) * | 2006-01-26 | 2007-11-27 | Общество С Ограниченной Ответственностью "Вдс" | Состав для реминерализации тканей зубов |
RU2361600C1 (ru) | 2007-12-25 | 2009-07-20 | Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Федерального агентства по здравоохранению и социальному развитию (ГОУВПО ММА им. И.М. Сеченова Росздрава) | Средство для лечения заболеваний пародонта |
EA011254B1 (ru) | 2008-02-07 | 2009-02-27 | Общество С Ограниченной Ответственностью "Вдс" | Гель для реминерализации тканей зубов |
RU2627624C1 (ru) | 2016-10-06 | 2017-08-09 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) | Средство для реминерализации твердых тканей зубов |
RU2677231C1 (ru) | 2017-10-10 | 2019-01-16 | Федеральное государственное бюджетное учреждение науки Институт химии твердого тела Уральского отделения Российской академии наук | Стоматологический гель для реминерализации твердых тканей зубов и способ реминерализации твердых тканей зубов |
Non-Patent Citations (4)
Title |
---|
"Klinicheskie aspekty primeneniya applikatsionnogo gelya R.O.C.S. MEDICAL MINERALS v profilaktike i lechenii kariesa zubov", UNIDENT TODAY, vol. 1, no. 12, January 2010 (2010-01-01), pages 1 - 46, XP055834799, Retrieved from the Internet <URL:http://www.unident.ru/files/6432/Today_12.pdf> [retrieved on 20200831] * |
J. A. KAIDONIS ET AL., J DENT RES, 1998 |
SAMARKINA ANASTASIA NIKOLAEVNA: "Mediko-sotsialnye aspekty lecheniya i profilaktiki fljuoroza zubov u detei, prozhivaiuschikh v endemicheskom ochage", DISSERTATION, 30 November 2016 (2016-11-30), Russia, pages 1 - 192, XP009529678 * |
See also references of EP4082511A4 |
Also Published As
Publication number | Publication date |
---|---|
KR20220119700A (ko) | 2022-08-30 |
RU2020128080A3 (ru) | 2022-02-24 |
BR112022012549A2 (pt) | 2022-09-06 |
EP4082511A1 (en) | 2022-11-02 |
CN114929179A (zh) | 2022-08-19 |
US20230034815A1 (en) | 2023-02-02 |
RU2020128080A (ru) | 2022-02-24 |
EP4082511A4 (en) | 2023-11-01 |
JP7439352B2 (ja) | 2024-02-28 |
JP2023508649A (ja) | 2023-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Balagopal et al. | Chlorhexidine: the gold standard antiplaque agent | |
Quirynen et al. | Review of the treatment strategies for oral malodour | |
Al Habashneh et al. | The effect of a triclosan/copolymer/fluoride toothpaste on plaque formation, gingivitis, and dentin hypersensitivity: A single-blinded randomized clinical study | |
CN110996891A (zh) | 包含氯己定的凝胶 | |
Nathoo et al. | A clinical study comparing the supragingival plaque and gingivitis efficacy of a specially engineered sonic powered toothbrush with unique sensing and control technologies to a commercially available manual flat-trim toothbrush. | |
Shapira et al. | A comprehensive 30‐month preventive dental health program in a pre‐adolescent population with Down's Syndrome: A longitudinal study | |
Twetman et al. | Interdental caries incidence and progression in relation to mutans streptococci suppression after chlorhexidine-thymol varnish treatments in schoolchildren | |
Hu et al. | A clinical investigation of the efficacy of a dual zinc plus arginine dentifrice for controlling oral malodor | |
EP0486561B2 (en) | Buccal composition containing s(+) ketoprofen | |
US20080112902A1 (en) | Protective Dental Balm and Method | |
RU2457829C2 (ru) | Минерально-витаминный комплекс для укрепления эмали зубов, композиция для гигиены полости рта и зубная паста | |
US20060239938A1 (en) | Dental balm and method of prevention of damage to teeth | |
RU2158125C1 (ru) | Состав для профилактики и лечения заболеваний пародонта и слизистой оболочки полости рта | |
RU2779298C2 (ru) | Состав для лечения и/или профилактики заболеваний, характеризующихся утратой минералов и солей из эмали зубов, и способ его применения | |
JP7439352B2 (ja) | 歯のエナメル質を再石灰化するための組成物 | |
Tamaki et al. | Study of the clinical usefulness of a dental drug system for selective reduction of mutans streptococci using a case series | |
EA041177B1 (ru) | Состав для лечения и/или профилактики заболеваний, характеризующихся утратой минералов и солей из эмали зубов, и способ его применения | |
RU2364389C1 (ru) | Средство для полоскания полости рта | |
Dhama et al. | Topical Fluorides. A literature review | |
RU2799030C1 (ru) | Стоматологический гель для реминерализации твердых тканей зубов | |
Borges et al. | Preventive Measures and Minimally Invasive Restorative Procedures | |
RU2090183C1 (ru) | Лечебно-профилактическая зубная паста "осинка" | |
CA2555095A1 (en) | Dental balm and method of prevention of damage to teeth | |
WO2020162793A2 (ru) | Способ ухода за полостью рта | |
RU2188626C1 (ru) | Состав для профилактики заболеваний зубов и пародонта |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19957491 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022535093 Country of ref document: JP Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112022012549 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 20227025643 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2019957491 Country of ref document: EP Effective date: 20220726 |
|
ENP | Entry into the national phase |
Ref document number: 112022012549 Country of ref document: BR Kind code of ref document: A2 Effective date: 20220623 |